DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Share Price

Certificat

DE000ME5F9X4

Market Closed - Börse Stuttgart 19:42:18 28/06/2024 BST
0.218 EUR -1.36% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month+77.24%
1 month+83.19%
Date Price Change
28/06/24 0.218 -1.36%
27/06/24 0.221 -0.45%
26/06/24 0.222 -5.13%
25/06/24 0.234 +21.88%
24/06/24 0.192 -1.03%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 07:42 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellPUT
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME5F9X
ISINDE000ME5F9X4
Date issued 15/12/2023
Strike 50 $
Maturity 20/12/2024 (175 Days)
Parity 10 : 1
Emission price 0.21
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.27
Lowest since issue 0.059
Spread 0.008
Spread %3.59%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.09 USD
Average target price
83.43 USD
Spread / Average Target
+46.14%
Consensus